A new study found that cannabis users under the age of 50 are about 6.2 times more likely to experience a heart attack than ...

U.S. Food and Drug Administration approved Alnylam's drug to treat a rare and deadly heart disease on Thursday, allowing the ...

Discover the life-extending approaches to managing heart failure through medication adherence, lifestyle modifications, and ...

Women of childbearing age who had both ovaries removed in a procedure called bilateral oophorectomy were more likely to ...

A protocol for transitioning patients with heart failure and a left ventricular assist device to a stepdown unit from the ICU ...

Affecting 1 in 500 people, hypertrophic cardiomyopathy is a condition in which the walls of the left ventricle, the heart's ...

More than four years after a 77-year-old man walked into a Florida hospital with pain in his chest, a new report says preparing and eating feral pig meat was the likely cause of the man’s yearslong ...

Alnylam Pharmaceuticals' shares rose more than 10% on Friday after the drugmaker secured U.S. approval for its heart disease drug, setting the stage for the 23-year-old biotech's next phase of growth.

Initially, Amvuttra’s annual list price will be nearly double the yearly cost of rival medicines from Pfizer and BridgeBio.

Discover how menopause affects heart health through hormonal changes, cholesterol shifts, body fat redistribution, blood ...

Researchers have shed new light on how a type of heart valve disease -- aortic valve stenosis -- progresses differently in males and females.